BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mendrone-Junior A, Dinardo CL, Ferreira SC, Nishya A, Salles NA, de Almeida Neto C, Hamasaki DT, Facincani T, de Oliveira Alves LB, Machado RRG, Araujo DB, Durigon EL, Rocha V, Sabino EC. Correlation between SARS-COV-2 antibody screening by immunoassay and neutralizing antibody testing. Transfusion 2021;61:1181-90. [PMID: 33491194 DOI: 10.1111/trf.16268] [Cited by in Crossref: 8] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Buss L, Prete CA, Whittaker C, Salomon T, Oikawa MK, Pereira RHM, Moura ICG, Delerino L, Franca RFO, Miyajima F, Mendrone Jr. A, Almeida-neto C, Salles NA, Ferreira SC, Fladzinski KA, de Souza LM, Schier LK, Inoue PM, Xabregas LA, Crispim MAE, Fraiji N, Carlos LMB, Pessoa V, Ribeiro MA, de Souza RE, Cavalcante AF, Valença MIB, da Silva MV, Lopes E, Filho LA, Mateos SOG, Nunes GT, Schlesinger D, da Silva SMN, Silva-junior AL, Castro MC, Nascimento VH, Dye C, Busch MP, Faria NR, Sabino EC. Predicting SARS-CoV-2 Variant Spread in a Completely Seropositive Population Using Semi-Quantitative Antibody Measurements in Blood Donors. Vaccines 2022;10:1437. [DOI: 10.3390/vaccines10091437] [Reference Citation Analysis]
2 Belitardo EM, Nery N, Ticona JP, Portilho MM, Mello IO, Ribeiro GS, Reis MG, Costa F, Cummings DA, Ko AI, Fofana MO. Reliable estimation of SARS-CoV-2 anti-spike protein IgG titers from single dilution optical density values in serologic surveys. Diagnostic Microbiology and Infectious Disease 2022. [DOI: 10.1016/j.diagmicrobio.2022.115807] [Reference Citation Analysis]
3 Leonard EK, Aller Pellitero M, Juelg B, Spangler JB, Arroyo-Currás N. Antibody-Invertase Fusion Protein Enables Quantitative Detection of SARS-CoV-2 Antibodies Using Widely Available Glucometers. J Am Chem Soc 2022;144:11226-37. [PMID: 35675509 DOI: 10.1021/jacs.2c02537] [Reference Citation Analysis]
4 Andreata-santos R, Machado RRG, Alves RPDS, Sales NS, Soares CP, Rodrigues KB, Silva MO, Favaro MTDP, Rodrigues-jesus MJ, Yamamoto MM, Andrade JBD, Fock RA, Margarido PFR, Carvalho CRG, Boscardin SB, Durigon EL, Ferreira LCS. Validation of Serological Methods for COVID-19 and Retrospective Screening of Health Employees and Visitors to the São Paulo University Hospital, Brazil. Front Cell Infect Microbiol 2022;12:787411. [DOI: 10.3389/fcimb.2022.787411] [Reference Citation Analysis]
5 Martínek J, Tomášková H, Janošek J, Zelená H, Kloudová A, Mrázek J, Ježo E, Král V, Pohořská J, Šturcová H, Maďar R. Immune Response 5–7 Months after Vaccination against SARS-CoV-2 in Elderly Nursing Home Residents in the Czech Republic: Comparison of Three Vaccines. Viruses 2022;14:1086. [DOI: 10.3390/v14051086] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Junker D, Dulovic A, Becker M, Wagner TR, Kaiser PD, Traenkle B, Kienzle K, Bunk S, Struemper C, Haeberle H, Schmauder K, Ruetalo N, Malek N, Althaus K, Koeppen M, Rothbauer U, Walz JS, Schindler M, Bitzer M, Göpel S, Schneiderhan-Marra N. COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutants. Sci Rep 2022;12:7168. [PMID: 35505068 DOI: 10.1038/s41598-022-10987-2] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Wünsch K, Anastasiou OE, Alt M, Brochhagen L, Cherneha M, Thümmler L, van Baal L, Madel RJ, Lindemann M, Taube C, Witzke O, Rohn H, Krawczyk A, Jansen S. COVID-19 in Elderly, Immunocompromised or Diabetic Patients—From Immune Monitoring to Clinical Management in the Hospital. Viruses 2022;14:746. [DOI: 10.3390/v14040746] [Reference Citation Analysis]
8 Girl P, Mantel S, von Buttlar H, Wölfel R, Müller K. Side-By-Side Evaluation of Three Commercial ELISAs for the Quantification of SARS-CoV-2 IgG Antibodies. Viruses 2022;14:577. [DOI: 10.3390/v14030577] [Reference Citation Analysis]
9 Sander I, Kespohl S, Zahradnik E, Göcke P, Hosbach I, Herrmann BL, Brüning T, Raulf M. Quantitative measurement of IgG to SARS‐CoV‐2 antigens using monoclonal antibody‐based enzyme‐linked immunosorbent assays. Clin & Trans Imm 2022;11. [DOI: 10.1002/cti2.1369] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Hu C, Li D, Liu Z, Ren L, Su J, Zhu M, Feng Y, Wang Z, Liu Q, Zhu B, Shao Y. Exploring Rapid and Effective Screening Methods for Anti-SARS-CoV-2 Neutralizing Antibodies in COVID-19 Convalescent Patients and Longitudinal Vaccinated Populations. Pathogens 2022;11:171. [DOI: 10.3390/pathogens11020171] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Mou L, Zhang Y, Feng Y, Hong H, Xia Y, Jiang X. Multiplexed Lab-on-a-Chip Bioassays for Testing Antibodies against SARS-CoV-2 and Its Variants in Multiple Individuals. Anal Chem 2022. [PMID: 35080377 DOI: 10.1021/acs.analchem.1c04383] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
12 Silva Jr ARD, Villas-boas LS, Tozetto-mendoza TR, Honorato L, Paula AD, Witkin SS, Mendes-correa MC. Generation of neutralizing antibodies against Omicron, Gamma and Delta SARS-CoV-2 variants following CoronaVac vaccination. Rev Inst Med trop S Paulo 2022;64:e19. [DOI: 10.1590/s1678-9946202264019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
13 Chapuy-Regaud S, Miédougé M, Abravanel F, Da Silva I, Porcheron M, Fillaux J, Diméglio C, Izopet J. Evaluation of Three Quantitative Anti-SARS-CoV-2 Antibody Immunoassays. Microbiol Spectr 2021;9:e0137621. [PMID: 34937195 DOI: 10.1128/spectrum.01376-21] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
14 Nam M, Seo JD, Moon HW, Kim H, Hur M, Yun YM. Evaluation of Humoral Immune Response after SARS-CoV-2 Vaccination Using Two Binding Antibody Assays and a Neutralizing Antibody Assay. Microbiol Spectr 2021;9:e0120221. [PMID: 34817223 DOI: 10.1128/Spectrum.01202-21] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
15 Zhang Q, Gong L, Zhang Y, Shen Y, Shen L, Cao L, Han G, Hu F, Zhao F, Chen Z. Room-temperature-storable chemiluminescence freeze-drying mixes for detection of SARS-CoV-2 neutralizing antibody. Drying Technology. [DOI: 10.1080/07373937.2021.2015604] [Reference Citation Analysis]
16 Achiron A, Mandel M, Dreyer-Alster S, Harari G, Dolev M, Menascu S, Magalashvili D, Flechter S, Givon U, Guber D, Sonis P, Zilkha-Falb R, Gurevich M. Humoral immune response in multiple sclerosis patients following PfizerBNT162b2 COVID19 vaccination: Up to 6 months cross-sectional study. J Neuroimmunol 2021;361:577746. [PMID: 34655991 DOI: 10.1016/j.jneuroim.2021.577746] [Cited by in F6Publishing: 20] [Reference Citation Analysis]
17 Tukhvatulin AI, Dolzhikova IV, Shcheblyakov DV, Zubkova OV, Dzharullaeva AS, Kovyrshina AV, Lubenets NL, Grousova DM, Erokhova AS, Botikov AG, Izhaeva FM, Popova O, Ozharovskaia TA, Esmagambetov IB, Favorskaya IA, Zrelkin DI, Voronina DV, Shcherbinin DN, Semikhin AS, Simakova YV, Tokarskaya EA, Shmarov MM, Nikitenko NA, Gushchin VA, Smolyarchuk EA, Zubkova TG, Zakharov KA, Vasilyuk VB, Borisevich SV, Naroditsky BS, Logunov DY, Gintsburg AL. An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine "Sputnik Light" for prevention of coronavirus infection in healthy adults. Lancet Reg Health Eur 2021;11:100241. [PMID: 34746910 DOI: 10.1016/j.lanepe.2021.100241] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
18 Rechavi Y, Shashar M, Lellouche J, Yana M, Yakubovich D, Sharon N. Occurrence of BNT162b2 Vaccine Adverse Reactions Is Associated with Enhanced SARS-CoV-2 IgG Antibody Response. Vaccines (Basel) 2021;9:977. [PMID: 34579214 DOI: 10.3390/vaccines9090977] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
19 Bennett RS, Postnikova EN, Liang J, Gross R, Mazur S, Dixit S, Kocher G, Yu S, Georgia-Clark S, Gerhardt D, Cai Y, Marron L, Lukin VV, Holbrook MR. Scalable, Micro-Neutralization Assay for Assessment of SARS-CoV-2 (COVID-19) Virus-Neutralizing Antibodies in Human Clinical Samples. Viruses 2021;13:893. [PMID: 34065987 DOI: 10.3390/v13050893] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
20 Achiron A, Gurevich M, Falb R, Dreyer-Alster S, Sonis P, Mandel M. SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects. Clin Microbiol Infect 2021;27:1349.e1-6. [PMID: 33975009 DOI: 10.1016/j.cmi.2021.05.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
21 Laterza R, Schirinzi A, Bruno R, Genco R, Contino R, Ostuni A, Di Serio F. SARS-CoV-2 antibodies: Comparison of three high-throughput immunoassays versus the neutralization test. Eur J Clin Invest 2021;51:e13573. [PMID: 33870493 DOI: 10.1111/eci.13573] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
22 Achiron A, Mandel M, Dreyer-Alster S, Harari G, Magalashvili D, Sonis P, Dolev M, Menascu S, Flechter S, Falb R, Gurevich M. Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies. Ther Adv Neurol Disord 2021;14:17562864211012835. [PMID: 34035836 DOI: 10.1177/17562864211012835] [Cited by in Crossref: 28] [Cited by in F6Publishing: 110] [Article Influence: 28.0] [Reference Citation Analysis]
23 De Santis GC, Mendrone A, Langhi D Jr, Covas DT, Fabron A Jr, Cortez AJP, Dinardo CL, Ubiali EMA, Marques JFC Jr, Bordin JO, Rugani MA. Suggested guidelines for convalescent plasma therapy for the treatment of COVID-19. Hematol Transfus Cell Ther 2021;43:212-3. [PMID: 33778377 DOI: 10.1016/j.htct.2021.03.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
24 Bennett RS, Postnikova EN, Liang J, Gross R, Mazur S, Dixit S, Lukin VV, Kocher G, Yu S, Georgia-Clark S, Gerhardt D, Cai Y, Marron L, Holbrook MR. Scalable, Micro-Neutralization Assay for Qualitative Assessment of SARS-CoV-2 (COVID-19) Virus-Neutralizing Antibodies in Human Clinical Samples. bioRxiv 2021:2021. [PMID: 33688658 DOI: 10.1101/2021.03.05.434152] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]